My opinion only and don’t want a argument. FDA will approve Elevidys and I can’t see them partnering with PER as they have spent substantial amount of money already on their DMD pipeline. If we gain a partner, it will be somebody in competition to Sarpeta Cheers
My opinion only and don’t want a argument. FDA will approve...
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.6¢ |
Change
0.001(1.33%) |
Mkt cap ! $68.51M | |||
| Open | High | Low | Value | Volume |
| 7.5¢ | 7.9¢ | 7.5¢ | $38.02K | 490.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 18755 | 7.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.9¢ | 26315 | 1 |
View Market Depth
| Last trade - 15.42pm 20/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.9¢ |
Change
0.001 ( 5.33 %) |
||||
| Open | High | Low | Volume | ||
| 7.7¢ | 7.9¢ | 7.6¢ | 44728 | ||
| Last updated 15.53pm 20/05/2024 ? | |||||
| PER (ASX) Chart |